Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Havrix Co-administered with Prevnar in Toddlers
NCT00197002Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Primary completion
- Jan 2006
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis A virus vaccine in hepatitis A (HAV), sponsored by GSK. Started Sep 2003; status: completed.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00197002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197002.